Originally published 24 January 2018. Editorially updated 13 October 2026. Historical research commentary, not individual medical advice.

What did researchers observe?

In 2018, a case report described a person receiving cancer immunotherapy who appeared to have a reduction in some measures of HIV-infected cells. This was an observation in an individual treated for cancer, not proof that immunotherapy cures HIV.

What happened to the original headline?

The phrase “HIV breakthrough” could imply an established treatment where there was none. Different patients, different cancers and different antiretroviral regimens can lead to different outcomes, and a single case cannot establish safety or effectiveness for routine HIV care.

What should patients know today?

Effective antiretroviral therapy remains the foundation of HIV care. Cancer immunotherapy should only be used for appropriate clinical indications under specialist supervision; it is not a standard treatment for curing HIV. Clinical research into HIV remission continues, but patients must not change or stop ART because of an early research report.